JPWO2021054440A1 - - Google Patents

Info

Publication number
JPWO2021054440A1
JPWO2021054440A1 JP2021546977A JP2021546977A JPWO2021054440A1 JP WO2021054440 A1 JPWO2021054440 A1 JP WO2021054440A1 JP 2021546977 A JP2021546977 A JP 2021546977A JP 2021546977 A JP2021546977 A JP 2021546977A JP WO2021054440 A1 JPWO2021054440 A1 JP WO2021054440A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021546977A
Other languages
Japanese (ja)
Other versions
JP7313019B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021054440A1 publication Critical patent/JPWO2021054440A1/ja
Application granted granted Critical
Publication of JP7313019B2 publication Critical patent/JP7313019B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2021546977A 2019-09-20 2020-09-18 医薬組成物 Active JP7313019B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019170955 2019-09-20
JP2019170955 2019-09-20
PCT/JP2020/035438 WO2021054440A1 (ja) 2019-09-20 2020-09-18 医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2021054440A1 true JPWO2021054440A1 (https=) 2021-03-25
JP7313019B2 JP7313019B2 (ja) 2023-07-24

Family

ID=74883058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546977A Active JP7313019B2 (ja) 2019-09-20 2020-09-18 医薬組成物

Country Status (10)

Country Link
US (1) US20220347093A1 (https=)
EP (1) EP4032535A4 (https=)
JP (1) JP7313019B2 (https=)
CN (3) CN114650828B (https=)
AU (1) AU2020349263B2 (https=)
BR (1) BR112022003464A2 (https=)
CA (1) CA3154360C (https=)
MY (1) MY206715A (https=)
PH (1) PH12022550661A1 (https=)
WO (1) WO2021054440A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3144752A1 (fr) * 2023-01-10 2024-07-12 Song Huang Utilisation de polysulfate de pentosane pour le traitement de la toux seche

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503090A (ja) * 2005-08-03 2009-01-29 モリア・バイオファーマシューティカルズ 嚢胞性線維症における脂質複合体の使用及びその適用
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
JP2014534214A (ja) * 2011-10-27 2014-12-18 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 慢性副鼻腔炎の処置における脂質コンジュゲート

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3497209B2 (ja) 1993-08-24 2004-02-16 生化学工業株式会社 硫酸化糖の脱硫酸化方法
JP3512277B2 (ja) 1995-10-05 2004-03-29 有限会社ジーオーメディカルサービス 鼻茸治療・予防剤
JPH10203988A (ja) 1997-01-27 1998-08-04 Meiji Milk Prod Co Ltd 鼻茸および鼻粘膜の浮腫性病変の治療剤
JPH11335288A (ja) * 1998-05-20 1999-12-07 Maruho Co Ltd アレルギー性疾患の予防または治療薬
WO2000069917A1 (fr) * 1999-05-18 2000-11-23 Maruho Kabushikikaisha Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2?
US20140005115A1 (en) * 2005-11-17 2014-01-02 Yissum Research Development Company Lipid conjugates in the treatment of bronchitis
CN111437387B (zh) 2013-06-21 2024-10-01 赛诺菲生物技术公司 通过施用il-4r拮抗剂治疗鼻息肉症的方法
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503090A (ja) * 2005-08-03 2009-01-29 モリア・バイオファーマシューティカルズ 嚢胞性線維症における脂質複合体の使用及びその適用
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
JP2014534214A (ja) * 2011-10-27 2014-12-18 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 慢性副鼻腔炎の処置における脂質コンジュゲート

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
SAKAI SHINOBU ET AL.: "Chondroitin Sulfate Intake Inhibits the IgE-mediated Allergic Response by Down-regulating Th2 Respon", J BIOL CHEM., vol. vol.281(29), JPN6020044365, 2006, pages 19872 - 19880, XP055807386, ISSN: 0005012672 *
SANDEN CAROLINE ET AL.: "Broad Th2 neutralization and anti-inflammatory action of pentosan polysulfate sodium in experimental", IMMUN INFLAMM DIS., vol. vol.5(3), JPN6020044366, 2017, pages 300 - 309, ISSN: 0005012673 *
TAKABAYASHI TETSUJI ET AL.: "Excessive Fibrin Deposition in Nasal Polyps Caused by Fibrinolytic Impairment through Reduction of T", AM J RESPIR CRIT CARE MED., vol. vol.187(1), JPN6020044363, 2013, pages 49 - 57, ISSN: 0005012675 *
大西伸和ほか: "NC/Ngaマウスの掻破行動及び皮膚局所Th2応答に対する微粉砕コンニャクグルコマンナンの抑制効果", アレルギー, vol. vol.55 No.8/9, JPN6020044368, 2006, pages 1124, ISSN: 0005012674 *
藤枝重治ほか: "疾患研究から次世代の治療に III.アレルギー性鼻炎 2.好酸球性副鼻腔炎", 実験医学, vol. 37, no. 10, JPN6020044369, 15 June 2019 (2019-06-15), pages 1697 - 1704, ISSN: 0005012676 *

Also Published As

Publication number Publication date
EP4032535A1 (en) 2022-07-27
CN114650828A (zh) 2022-06-21
CA3154360C (en) 2024-01-23
WO2021054440A1 (ja) 2021-03-25
AU2020349263B2 (en) 2023-08-17
CA3154360A1 (en) 2021-03-25
BR112022003464A2 (pt) 2022-05-24
CN118976045A (zh) 2024-11-19
CN118416094A (zh) 2024-08-02
US20220347093A1 (en) 2022-11-03
MY206715A (en) 2025-01-03
EP4032535A4 (en) 2023-10-25
JP7313019B2 (ja) 2023-07-24
AU2020349263A1 (en) 2022-04-14
PH12022550661A1 (en) 2023-03-27
CN114650828B (zh) 2024-08-06

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021017939A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112019016138A2 (https=)
BR112019016142A2 (https=)
BR112021017732A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
AT524962A5 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220330

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230314

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230620

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230703

R150 Certificate of patent or registration of utility model

Ref document number: 7313019

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150